US-based Sofinnova Ventures has a led a $57m series-B round for biopharmaceutical company Nucana, alongside existing European investors.
Fund has an €80m target and invests in seed, series-A and series-B rounds in the space technology sector
Sale follows a competitive process initiated in July 2019 as part of the company's restructuring
Bolt-on of cable installation market peer is subject to competition authority approval
GP acquired a majority stake in the Romanian recycling business in April 2016